Inicio > Alergología > Efecto del Montelukast Sódico en Asma Bronquial y Rinitis Alérgica > Página 7

Efecto del Montelukast Sódico en Asma Bronquial y Rinitis Alérgica

35.  Van Adelsberg J, Philip G, Pedinoff AJ, Meltzer EO, Ratner PH, Menten J, et al. Montelukast improves symptoms of seasonal allergic rhinitis over a 4-week treatment period. Allergy. 2009;58:12:1268-76.

36.  Chervinsky P, Philip G, Malice MP, Bardelas J, Nayak A, Marchal JL, et al. Montelukast for treating fall allergic rhinitis:effect of pollen exposure in 3 studies. Ann Allergy Asthma Immunol. 2004;92:3:367-73.

37.  Pullerits T, Praks L, Ristioja V, Lotvall J. Comparison of nasal glucocorticoid, antileucotriene, and combination of antileukotriene and antihistamine in the treatment of seasonal allergic rhinitis. J Allergy Clin Immunol. 2008;109:6:949-55.

38.  Di Lorenzo G, Pacor ML, Pellitteri ME, Morici G, DI Gregoli A, LO Blanco C, et al. Randomized placebo-controlled trial comparing fluticasone aqueous nasal spray in mono-therapy, fluticasone plus cetirizine, fluticasone plus montelukast and cetirizine plus montelukast for seasonal allergic rhinitis. Clin Exp Allergy. 2004;34:2:259-67.

39.  Laviolette M, Malmstrom K, Lu S, et al. Montelukast added to inhaled beclomethasone in treatment of asthma. Montelukast/Beclomethasone Additivity Group. Am J Respir Crit Care Med. 1999;160 1862–8.

40.  Lofdahl CG, Reiss TF, Leff JA, et al. Randomised, placebo controlled trial of effect of a leukotriene receptor antagonist, montelukast, on tapering inhaled corticosteroids in asthmatic patients. BMJ. 1999; 319: 87–90.

41.  Price DB, Hernandez D, Magyar P, et al. Randomised controlled trial of montelukast plus inhaled budesonide versus double dose inhaled budesonide in adult patients with asthma. Thorax. 2003;58:211–6.

42.   Vaquerizo MJ, Casan P, Castillo J, et al. Effect of montelukast added to inhaled budesonide on control of mild to moderate asthma. Thorax. 2003;58:204–10.

43.  Virchow JC, Prasse A, Naya I, Summerton L, Harris A. Zafirlukast improves asthma control in patients receiving high-dose inhaled corticosteroids. Am J Respir Crit Care Med. 2000;162:578–85.

44.  Bateman ED, Hurd SS, Barnes PJ, Bousquet JJ, Drazen JM, FitzGeralde M, et al. Global strategy for asthma management and prevention: GINA executive summary. Eur Respir J. 2008;31(1):143–78.